News und Analysen
Why Merck Stock Slipped Today
On Tuesday, Merck (NYSE: MRK) wasn't one of the better-performing pharmaceutical stocks. In contrast to certain peers, the company's share price declined following the release of second-quarter
Merck Posts Q2 EPS Beat Revenue Slips
Merck (NYSE:MRK), a leading developer of prescription medicines, vaccines, and animal health products, released its second-quarter 2025 results on July 29, 2025. The most notable news was a beat on
Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever
Healthcare stocks aren't exactly known for offering large yields, with the average healthcare stock at just 1.8% or so. You can do better than that and get reliable dividend stocks while you are at
5 Dividend Stocks to Hold for the Next 20 Years
These five dividend giants (plus two honorable mentions) aren't just income plays -- they're global titans with decades of growth, consistent payouts, and bulletproof brands. From Coca-Cola's (NYSE:
EQS-News: PUMA reports sales decline in Q2 and lowers outlook for 2025
EQS-Adhoc: PUMA announces preliminary results for the second quarter and lowers its outlook for 2025
EQS-Adhoc: Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München: Supervisory Board decides on changes to the Board of Management
EQS-News: Sartorius continues growth course; earnings rise at a significantly overproportionate rate
EQS-Adhoc: Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München: Munich Re posts quarterly result of €2.1bn
Does This Move Make Merck Stock a Buy?
Merck (NYSE: MRK), a leading pharmaceutical company, generates consistent revenue and profits. However, the stock has been under pressure over the past year due to its reliance on Keytruda, its
Merck Just Announced a $10 Billion Deal That Will Help Diversify Its Business
One of the biggest concerns with healthcare giant Merck (NYSE: MRK) is its dependence on top-selling cancer drug Keytruda. While it has been a beast for the business over the years, generating
PUMA and Manchester City Announce Long-Term Extension to Successful Global Partnership
Sports company PUMA and Premier League football club Manchester City have signed a long-term extension of their partnership, which since the 2019/20 season has exceeded all expectations on and off
PUMA und Manchester City geben langfristige Verlängerung ihrer erfolgreichen Partnerschaft bekannt
Das Sportunternehmen PUMA und der Premier League-Fußballverein Manchester City haben eine langfristige Verlängerung ihrer Partnerschaft unterzeichnet, die seit der Saison 2019/20 alle Erwartungen
EQS-Adhoc: Brenntag SE publishes preliminary results for the second quarter of 2025 and adjusts its guidance for the financial year 2025
EQS-Adhoc: BASF SE: BASF Group releases preliminary figures for second quarter of 2025 and adjusts outlook for full-year 2025
2 Top Stocks Down 16% and 17% This Year to Buy and Hold
Most people love a bargain; investors do too. Purchasing shares of companies that can perform well over long periods is already pretty exciting, but it's even more so when they can be scooped up
EQS-News: Zalando and ABOUT YOU Successfully Complete Transaction and Team Up to Lead the Way in European Fashion and Lifestyle E-commerce
EQS-Adhoc: Daimler Truck Holding AG announces new share buyback program
PUMA and Borussia Dortmund Extend Partnership
Sports company PUMA has extended its long-standing partnership with Borussia Dortmund, and will continue to create products that cater to BVB’s many passionate fans around the world and match the
PUMA und Borussia Dortmund verlängern Partnerschaft
Das Sportunternehmen PUMA hat seine langjährige Partnerschaft mit Borussia Dortmund verlängert und wird auch in Zukunft Produkte entwickeln, die die vielen leidenschaftlichen Fans des BVB auf der
EQS-News: Zalando and ABOUT YOU Receive Final Regulatory Clearance to Team Up, with Closing Planned for 11 July 2025
EQS-News: Sartorius completes acquisition of MatTek
EQS-News: Announcement pursuant to Art. 5 para 1 of Regulation (EU) No. 596/2014 in conjunction with Art. 2 para 1 of the Delegated Regulation (EU) 2016/1052 of the Commission
EQS-News: AUMOVIO to Focus on Value- and Growth-oriented Development